Genetic risk assessment of lethal prostate cancer using polygenic risk score and hereditary cancer susceptibility genes.
Xiaohao RuanDa HuangJingyi HuangJames Hok-Leung TsuRong NaPublished in: Journal of translational medicine (2023)
Our findings provide a new measurement of PCa patients' natural disease outcomes via genetic risk ways.